Stoke Therapeutics STOK Q1 2026 Earnings Beat Revenue NA EPS 079 PPL PPLC Q1 2026 Earnings 063 EPS Surges Past 062 Estimates 30Year Yield Surges to Great Recession Levels Are Bond Vigilantes Back Xi Jinping Pledges Wider Market Access for US Firms During Trump Visit